NanoStilbene Clinical Trial – These results suggest that NanoStilbene may be a useful adjuvant to immunotherapy of cancer rescuing T cell and NK cell activities.

NanoStilbene PK Study – NanoStilbene Administration Results in Superior Pharmacokinetic Profi­le Compared to Pterostilbene Administration.

Pterostilbene Literature Review – Cancer and Pterostilbene Comprehensive Literature Review.